Announcement
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 24 Sep
Source: Bse
Mukka Proteins Limited (MUKKA)
Small CapConsumer stocks · Small cap · NSE
Mukka Proteins Limited operates in Marine Products, within the Consumer sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.
₹25.83
-1.19 · -4.40%
Market cap ₹807 Cr
Data qualityFresh enough for analysisQuote updated 21 Oct, 03:31 pm ISTDetails
Quote21 Oct, 03:31 pm IST
Base fundamentals06 Oct 2026 · screener
Latest result12 Aug, 05:03 pm IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags03 May 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Consumer P/E 22.2 (n=441)
Technical timing lens
Trend score and candlestick chart
39BearishSMA20 -4.7% / mo · MACD − · sector -4.6pp vs Nifty 500 (3M)
Stock trend: 45
Sector RS: 31
Sector 3M: -10.2% vs Nifty 500 -5.6%
Consumer FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
MUKKAD candles · FIT view+5.9%Latest close ₹25.83 on 2026-10-21
Bar
-4.7%
RSI
42
MACD hist
-0.04
52W pos
50%
2026-10-21O ₹27.10H ₹27.95L ₹25.68C ₹25.83Vol 2.5L sh
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
MUKKANifty Consumer DurablesNifty 500
- MUKKA
- +11.7%
- Nifty 500
- -6.5%
- Nifty Consumer Durables
- -11.0%
- Vs Nifty 500
- +18.2 pp
Chart stats
21 Oct 2026- From 52W high
- -22.4%
- 52W range position
- 50%
- ATR (14)
- 6.0%
- Volume vs 20D
- 1.02x
- Avg traded value
- ₹0.7 Cr
- 20D price channel
- ₹24.8 - ₹30.3
₹33.3
₹18.3 - ₹33.3
₹1.6
Latest completed session
20-session average
40.3% annualized volatility
Research snapshot
What the evidence says now
Mixed fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is mixed.
Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · FAIR VALUE49
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Excellent100
Revenue +186.6% · PAT +850.0% YoY
Technical
Bearish39
Price trend and sector-relative-strength timing.
Valuation
Legacy model+66.4%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence56
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 30 Jun 2026
Excellent · 100/100Rev +187% YoY · PAT +850% YoY · margin expansion · +29% QoQ · operating leverage
Filed 12 Aug 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹490 Cr | +186.6% | +28.6% |
| EBITDA | ₹47 Cr | +235.7% | +38.2% |
| Operating margin | 10.0% | +200 bps | +100 bps |
| PAT | ₹19 Cr | +850.0% | -9.5% |
| PAT margin | 3.9% | +271 bps | -163 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- 11.70
- P/B
- 1.61
- EV/EBITDA
- 9.61
- Market Cap
- 807.00Cr
Profitability
- ROE
- 11.10%
- ROCE
- 11.60%
- ROA
- 4.57%
- Dividend Y
- —
Growth (CAGR)
- Revenue 5Y
- 19.00%
- EPS 5Y
- 53.00%
- Revenue 3Y
- 7.00%
- EPS 3Y
- 6.00%
Balance Sheet
- Debt/Equity
- 1.56
- Interest Coverage
- 2.49×
- Altman Z
- 2.34
- Book Value
- 16.60
Cash Flow
- FCF Yield
- —
- FCF Positive Y
- 0/5
- OCF
- -111.00 Cr
- EPS TTM
- 2.31
Shareholding
- Promoter Hold
- 73.33%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 56%
Financial History
Updated 21/10/2026
Revenue
₹ CrLatest: 490+28.6% vs prev
Net Profit
₹ CrLatest: 19.0-9.5% vs prev
ROE is shown only in the Annual view — quarterly equity data isn't published.
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Daily technical trend read
Bearish setupTrend is weak — long-term uptrend intact. RSI 42.
- Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
- SMA20 falling (~4.9% over last month) — short-term momentum negative.
- RSI(14) at 42 — falling, no extreme reading.
- MACD below signal but histogram contracting — bearish momentum easing.
- 22% off 52W high · 41% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
72
RS percentile
Stage 2 UptrendEstablished S2
1M return
-8.6%
3M return
+11.7%
6M return
+7.6%
1Y return
+2.5%
RS 1D
-1
RS 20D
+2
Sector rank
#8
Industry rank
#28
Stage evidence
- Price is 5.7% above the 30-week proxy.
- The 50-DMA is above the 30-week proxy and its slope is rising +2.7%.
- Both 3-month and 6-month returns are positive.
50-DMA
price below
200-DMA
price above
S2 entered
19 Aug 2026
S2 age
43 trading sessions
Sector
neutral
Industry
improving
Relative-strength line vs Nifty 500 (base 100)
262 observations
21 Oct 2026Value 102.15-3.51%
RS vs Nifty 500102
Valuation & peers
U-Score 49 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies
Valuation & peers
U-Score 49 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies
Deep Value
Fundamental score breakdown
U band · FAIR VALUEValuation22/30
Growth20/25
Quality3/20
Balance Sheet3/15
Cash Flow0/10
Piotroski
4/9 (+1)
Penalties
0
Raw sum
49
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
49/100 · legacy band FAIR VALUE
Positive drivers
- Fair-value margin of safety is positive at 66.4%.
- Growth contributes 20/25 to the score.
- Valuation contributes 22/30 to the score.
Main drags
- Cash flow is weaker at 0/10; verify the latest quarterly trend.
- Quality is weaker at 3/20; verify the latest quarterly trend.
- Balance sheet is weaker at 3/15; verify the latest quarterly trend.
Sector valuation model
Consumer valuation: PE/PEG and brand-quality premium
Consumer franchises can deserve higher multiples, but only when growth quality supports them.
Primary lens
PE and PEG relative to growth, ROE, margins, and brand strength.
Secondary checks
Volume growth, pricing power, distribution, same-store or category growth.
Main risk check
Premium valuation needs durable growth and margin resilience.
PE
11.7
PB
1.6
EV/EBITDA
9.6
ROE
11.1%
ROCE
11.6%
FCF Yield
—
Debt/Equity
1.6
MoS
+66.4%
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
49
Previous: 49
Legacy U-Score band
FAIR VALUE
Previous: FAIR VALUE
Margin of safety
+66.4%
Previous: +64.9%
Score history
12 stored score snapshots. Latest stored move: +0 points.
21 Oct 2026
v4.3-runtime-valuation
49
49
49
49
49
47
47
47
47
47
49
49
Factor attribution
No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Modelled fair value
Graham Number
₹29.37
+12.1% MoS
Growth-justified P/E
33.3
Growth-justified Value
₹76.92
+66.4% MoS
PEG
0.34
Comparable companies
Peers
Business-comparable peers in Consumer — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
IFBAGRO
Small
IFB Agro Industries Limited
Agro Processing
match 61
44
13.7
8.9%
-23%
WATCHLIST
MAGADSUGAR
Small
Magadh Sugar & Energy Limited
Agro Processing
match 61
56
14.7
7.4%
+53%
FAIR VALUE
DBOL
Small
Dhampur Bio Organics Limited
Agro Processing
match 61
62
32.3
2.6%
+69%
UNDERVALUED
DWARKESH
Small
Dwarikesh Sugar Industries Limited
Agro Processing
match 60
23
56.3
3.8%
-2261%
OVERVALUED
BCLIND
Small
Bcl Industries Limited
Agro Processing
match 58
75
7.9
13.4%
+78%
DEEP VALUE
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Issuer presentation review pending
Mukka Proteins Limited operates in Marine Products, within the Consumer sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Jun 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.
Trust Score
56Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 18th percentile of the scored universe and 20th percentile within Consumer. Main check: cash conversion is weak at 28/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 05 Sept 2026
management-trust-v1
16 docs text-extracted · 0 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
18th percentile
overall median 67 · Consumer: 20th pctile, median 66 · Small: 20th pctile, median 66
Evidence depth
Financial-only
16 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Needs extra due diligence; demand valuation comfort and recent improvement.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
86
strong · holding, pledge, alignment
Cash flow
28
weak · profit to cash conversion
Balance sheet
53
watch · leverage and solvency
Discipline
50
watch · capital discipline
Results
74
acceptable · quarterly consistency
Trust positives
- ▸Promoter holding is 73.3%.
- ▸Promoter pledge is zero.
- ▸3/4 latest quarters had positive YoY revenue growth.
- ▸3/4 latest quarters had positive YoY PAT growth.
Trust risks
- ▸Operating cash flow is negative at ₹-111 Cr.
- ▸Only 0 years of positive FCF.
- ▸Debt/equity is 1.56.
- ▸ROCE trend is -2.7%.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching Mukka Proteins Limited
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
Announcement
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 22 Sep
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 12 Sep
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Allotment 10 Sep - Board allotted 2 crore convertible warrants at Rs 23.50 each, raising Rs 47 crore on 10-09-2026.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 19 Aug - Intimation regarding Newspaper publication of Notice of 16th Annual General Meeting.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Aug - Newspaper publication of intimation of 16th Annual General Meeting.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Acquisition 12 Jun - Board approved 51% stake acquisition in Aqua Marine for up to Rs. 15 crore by 30-09-2026.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Preferential Issue 12 Jun - Mukka Proteins applied for in-principle approval for 2 crore convertible warrants at ₹23.50, aggregating to ₹47 crore.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Acquisition 12 Jun - Board approved 51% stake acquisition in Delta Marine Products for up to Rs 11.1 crore by 30-Sep-2026.
Source: Bse
Credit rating
Announcement under Regulation 30 (LODR)-Credit Rating 26 May - CARE downgraded Mukka Proteins' ₹495 crore bank facilities to BBB-/A3 with negative outlook.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 16 May
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Press Release / Media Release 16 May - FY26 revenue rose 44% to ₹1,449.5 crore; EBITDA ₹145.3 crore, PAT ₹57.1 crore; Oman, Sri Lanka expansion.
Source: Bse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.